• Home
  • 2019 VISION
  • LPBI Group
  • LPBI Group News
  • 2019 VISTA
  • HealthCare INVESTOR’s Corner ($)
  • Journal PharmaceuticalIntelligence.com
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder
  • Funding, Deals & Partnerships
  • Praising LPBI
  • CALENDAR
  • Contact Us
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • Audio Podcasts
  • NEWSLETTER
Advertisements

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com

Feeds:
Posts
Comments

BioMEMS – TEAM PRESENTATIONS 1/4/2016 – 3/31/2016

THURSDAY Presentations on BioMEMS

 

 

 

Date AM EST Time Name Topic
1/7/16 10:00 Dr. Pearlman Medical Implants and Surgery
1/7/16 10:00 Dr. Irina Engineering Tissue, Cell tissue engineering  with BioMEMS
1/14/16 10:00 Dr. Evelina Cohn “Promising molecules for cell detection in environmental and clinical samples:DNA/peptide co-assembly”
1/21/16 10:00 Aviva & Gerard Topic: Oligonucleotide chips

BioMEMS The Market aspects of Oligonucleotide-Chips, Products and Applications, Competition, January 21, 2016

Curator: Gérard LOISEAU, ESQ

https://pharmaceuticalintelligence.com/2016/02/02/biomems-the-market-aspects-of-oligonucleotide-chips-products-applications-competition-january-21-2016/

Gene Editing: The Role of Oligonucleotide Chips

Curators: Larry H Bernstein & Aviva Lev-Ari, PhD, RN

https://pharmaceuticalintelligence.com/2016/01/07/gene-editing-the-role-of-oligonucleotide-chips/

 

 
1/28/16 10:00 Dr. CodringtonDr. Williams APSTutorial on using WordPress on our Platform
2/4/16 10:00 Dr. Stu Cantor 6 Bio-MEMS in medical implants and surgery
6.1 Implantable microelectrodes
6.2 Microtools for surgery
6.3 Drug delivery

Bio-MEMS Technologies: Devices, Tissue Engineering, & Drug Delivery.     Presentation by Stuart Cantor, Ph.D. on 2/4/16

Curator: Stuart Cantor, Ph.D.

https://pharmaceuticalintelligence.com/2016/02/08/bio-mems-presentation-by-stuart-cantor-ph-d-on-2416/

 
2/11/16 No Meeting
2/18/16 10:00 Dr. WilliamsBill Zurn Human Factor Engineering: New Regulations Impact Drug Delivery, Device Design And Human Interaction

https://pharmaceuticalintelligence.com/2016/02/17/human-factor-engineering-new-regulations-impact-drug-delivery-device-design-and-human-interaction/ 
2/25/16 10:00 Dr. Williams  TUTORIAL E-PUBLISHING: CURATION
10:00 Dr. Danut Dragoi BioMEMS based  Optical Sensors
3/3/16 10:00 Dr. Codrington

‘Early identification of biomarkers for the delivery of personalised

therapy’
10-Mar 10:00 Dr. Nir TBA
3/17/16 10:00 Dr. Williams

BioMems cell signaling PCR,

micro arrays and beyond
24-Mar 10:00 DR. Sant TBA
31-Mar

 

 10:00 Tilda  

 

 
Advertisements

Share this:

  • Twitter
  • Facebook
  • LinkedIn
  • Print
  • Email

Like this:

Like Loading...

Advertisements

  • Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,514 other followers

  • Recent Posts

    • At Technical University of Munich (TUM) Successful Genetical modification of a patient’s own immune cells, T cell receptors, using CRISPR-Cas9 gene editing tool. The engineered T cells are very similar to the physiological immune cells. July 17, 2019
    • scPopCorn: A New Computational Method for Subpopulation Detection and their Comparative Analysis Across Single-Cell Experiments July 16, 2019
    • Engineered Bacteria used as Trojan Horse for Cancer Immunotherapy July 13, 2019
    • @BroadInstitute a shift from Permanently editing DNA to Temporarily revising RNA – An approach with promise for addressing the risk of developing Alzheimer’s by deactivating APOE4 – RESCUE: RNA Editing for Specific C to U Exchange, the platform builds on REPAIR: RNA Editing for Programmable A to I July 12, 2019
    • FIVE Forthcoming Books on CRISPR in 2019-2020: Flooded market or CRISPR-fatigued readers – Not to Worry !!!!! July 4, 2019
    • Prediction of Cardiovascular Risk by Machine Learning (ML) Algorithm: Best performing algorithm by predictive capacity had area under the ROC curve (AUC) scores: 1st, quadratic discriminant analysis; 2nd, NaiveBayes and 3rd, neural networks, far exceeding the conventional risk-scaling methods in Clinical Use July 4, 2019
    • The Health Care Benefits of Combining Wearables and AI July 2, 2019
    • Top 12 Artificial Intelligence Innovations Disrupting Healthcare by 2020 July 2, 2019
    • In-House Development of an intellectual property value calculator (IP-V-Cal) for Valuation of INTANGIBLE products: Intellectual property (IP) assets of Digital Printed Products (DPP) – Online Journal(s), e-Books and a Corpus of Real Time generated eProceedings of the Top Biotech Global Conferences June 30, 2019
    • Narrative Building for the Future of LPBI Group: List of Talking Points June 30, 2019

  • Archives

  • Categories

  • Meta

    • Register
    • Log in
    • Entries RSS
    • Comments RSS
    • WordPress.com

    • 2012pharmaceutical
    • Aashir Awan, Phd
    • Alan F. Kaul, PharmD., MS, MBA, FCCP
    • alexcrystal6
    • amnondanzig1724
    • anamikasarkar
    • apreconasia
    • aviralvatsa
    • David Orchard-Webb, PhD
    • danutdaagmailcom
    • Demet Sag, Ph.D., CRA, GCP
    • Dror Nir
    • evelinacohn
    • Gail S Thornton
    • Irina Robu
    • jdpmd
    • kellyperlman
    • Ed Kislauskis
    • larryhbern
    • lmulligan13gmailcom
    • marzankhan
    • megbaker58
    • pkandala
    • Rosalind Codrington, PhD
    • ritusaxena
    • Rick Mandahl
    • sjwilliamspa
    • stuartlpbi
    • Dr. Sudipta Saha
    • tildabarliya
    • zraviv06
    • zs22
    • Advertisements

Blog at WordPress.com.

WPThemes.


loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
%d bloggers like this: